Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-surgical feasibility study of doxycycline + azithromycin + vitamin C in early breast cancer
2019-004074-25Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of doxycycline, azithromycin and ascorbic acid in breast cancer (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Change in Ki67 expression. Started Oct 2020; status: active.
02
Drugs
doxycyclineazithromycinascorbic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2019-004074-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004074-25.